Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models

被引:94
|
作者
Kulak, Anita [1 ]
Steullet, Pascal [1 ]
Cabungcal, Jan-Harry [1 ]
Werge, Thomas [2 ]
Ingason, Andres [2 ]
Cuenod, Michel [1 ]
Do, Kim Quang [1 ]
机构
[1] Univ Lausanne Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Prilly, Switzerland
[2] Copenhagen Univ Hosp, Res Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, iPSYCH, Roskilde, Denmark
基金
瑞士国家科学基金会;
关键词
N-ACETYL-CYSTEINE; LIGASE MODIFIER SUBUNIT; MAGNETIC-RESONANCE-SPECTROSCOPY; GLUTATHIONE-DEFICIENT MICE; DOPAMINE UPTAKE INHIBITION; ANTERIOR CINGULATE CORTEX; PITUITARY-ADRENAL AXIS; TERM SPATIAL MEMORY; PREFRONTAL CORTEX; PREPULSE INHIBITION;
D O I
10.1089/ars.2012.4858
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Schizophrenia (SZ) and bipolar disorder (BD) are classified as two distinct diseases. However, accumulating evidence shows that both disorders share genetic, pathological, and epidemiological characteristics. Based on genetic and functional findings, redox dysregulation due to an imbalance between pro-oxidants and antioxidant defense mechanisms has been proposed as a risk factor contributing to their pathophysiology. Recent Advances: Altered antioxidant systems and signs of increased oxidative stress are observed in peripheral tissues and brains of SZ and BD patients, including abnormal prefrontal levels of glutathione (GSH), the major cellular redox regulator and antioxidant. Here we review experimental data from rodent models demonstrating that permanent as well as transient GSH deficit results in behavioral, morphological, electrophysiological, and neurochemical alterations analogous to pathologies observed in patients. Mice with GSH deficit display increased stress reactivity, altered social behavior, impaired prepulse inhibition, and exaggerated locomotor responses to psychostimulant injection. These behavioral changes are accompanied by N-methyl-D-aspartate receptor hypofunction, elevated glutamate levels, impairment of parvalbumin GABA interneurons, abnormal neuronal synchronization, altered dopamine neurotransmission, and deficient myelination. Critical Issues: Treatment with the GSH precursor and antioxidant N-acetylcysteine normalizes some of those deficits in mice, but also improves SZ and BD symptoms when given as adjunct to antipsychotic medication. Future Directions: These data demonstrate the usefulness of GSH-deficient rodent models to identify the mechanisms by which a redox imbalance could contribute to the development of SZ and BD pathophysiologies, and to develop novel therapeutic approaches based on antioxidant and redox regulator compounds. Antioxid. Redox Signal. 18, 1428-1443.
引用
收藏
页码:1428 / 1443
页数:16
相关论文
共 50 条
  • [41] Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application
    Watkins, C. C.
    Sawa, A.
    Pomper, M. G.
    TRANSLATIONAL PSYCHIATRY, 2014, 4 : e350 - e350
  • [42] Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder
    Boer, Simone
    Berk, Michael
    Dean, Brian
    NEUROSCIENCE LETTERS, 2009, 466 (01) : 27 - 29
  • [43] Multimodal assessments of the hippocampal formation in schizophrenia and bipolar disorder: Evidences from neurobehavioral measures and functional and structural MRI
    Knoechel, Christian
    Staeblein, Michael
    Storchak, Helena
    Reinke, Britta
    Jurcoane, Alina
    Prvulovic, David
    Linden, David E. J.
    van de Ven, Vincent
    Ghinea, Denisa
    Wenzler, Sofia
    Alves, Gilberto
    Matura, Silke
    Kroeger, Anne
    Oertel-Knoechel, Viola
    NEUROIMAGE-CLINICAL, 2014, 6 : 134 - 144
  • [44] Are preconceptional stressful experiences crucial elements for the aetiology of autism spectrum disorder? Insights from an animal model
    Pisu, Maria Giuseppina
    Boero, Giorgia
    Garau, Anna
    Casula, Claudia
    Cisci, Sonia
    Biggio, Francesca
    Concas, Alessandra
    Follesa, Paolo
    Maciocco, Elisabetta
    Porcu, Patrizia
    Serra, Mariangela
    NEUROPHARMACOLOGY, 2019, 157
  • [45] Adolescent cannabinoid exposure interacts with other risk factors in schizophrenia: A review of the evidence from animal models
    Dunn, Ariel L.
    Michie, Patricia T.
    Hodgson, Deborah M.
    Harms, Lauren
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2020, 116 : 202 - 220
  • [46] New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophrenia
    Neves, Gilda
    Antonio, Camila B.
    Betti, Andresa H.
    Pranke, Mariana A.
    Fraga, Carlos A. M.
    Barreiro, Eliezer J.
    Noel, Francois
    Rates, Stela M. K.
    BEHAVIOURAL BRAIN RESEARCH, 2013, 237 : 86 - 95
  • [47] Dynamic connectivity states estimated from resting fMRI Identify differences among Schizophrenia, bipolar disorder, and healthy control subjects
    Rashid, Barnaly
    Damaraju, Eswar
    Pearlson, Godfrey D.
    Calhoun, Vince D.
    FRONTIERS IN HUMAN NEUROSCIENCE, 2014, 8
  • [48] Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia
    Washizuka, Shinsuke
    Iwamoto, Kazuya
    Kakiuchi, Chihiro
    Bundo, Miki
    Kato, Tadafumi
    NEUROSCIENCE RESEARCH, 2009, 63 (03) : 199 - 204
  • [49] Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis
    McNamara, Robert K.
    Rider, Therese
    Jandacek, Ronald
    Tso, Patrick
    PSYCHIATRY RESEARCH, 2014, 215 (03) : 560 - 567
  • [50] The Emerging Role of Altered D-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies
    Errico, Francesco
    Nuzzo, Tommaso
    Carella, Massimo
    Bertolino, Alessandro
    Usiello, Alessandro
    FRONTIERS IN PSYCHIATRY, 2018, 9